Timothy P. Kelly

Insider Reports History

Entity
Individual
Location
C/O Homology Medicines, Inc., One Patriots Park, Bedford, MA
Signature
/s/ Barbara G. McClung, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy P. Kelly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Caribou Biosciences, Inc. Chief Technology Officer Option to purchase Common Stock 300K $807K $2.69 Jan 8, 2024 Direct
Homology Medicines, Inc. Chief Operating Officer Employee Stock Option (Right to Buy) 28.2K $378K $13.42 Feb 24, 2022 Direct
Homology Medicines, Inc. Chief Operating Officer Restricted Stock Units 4.8K $5.52K $1.15 Feb 24, 2022 Direct

Insider Reports Filed by Timothy P. Kelly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CRBU Caribou Biosciences, Inc. Jan 8, 2024 1 $0 4 Jan 9, 2024 Chief Technology Officer
CRBU Caribou Biosciences, Inc. Jan 1, 2024 0 $0 3/A Jan 10, 2024 Chief Technology Officer
CRBU Caribou Biosciences, Inc. Jan 1, 2024 0 $0 3 Jan 9, 2024 Chief Technology Officer
FIXX Homology Medicines, Inc. Feb 24, 2022 2 $0 4 Feb 28, 2022 Chief Operating Officer
FIXX Homology Medicines, Inc. Jan 1, 2022 3 -$5.31K 4 Jan 12, 2022 Chief Operating Officer
FIXX Homology Medicines, Inc. Sep 3, 2021 1 -$416 4 Sep 8, 2021 Chief Operating Officer
FIXX Homology Medicines, Inc. Mar 1, 2021 1 -$69.6K 4/A Sep 8, 2021 Officer